Global Scans · Pharmaceuticals · Weekly Summary

• [New] Pyrilutamide from Kintor Pharmaceutical met its Phase 3 primary endpoint in a 666-patient trial in China, with potential commercialization there in 2027. Shapiro Medical Group
• [New] The global pharmaceutical industry is expected to grow from approximately USD 1,627.73 billion in 2025 to USD 1,722.05 billion in 2026, representing a year-over-year growth rate of 5.8%. store.frost.com
• [New] The pharmaceutical corporation sells it for $28,000 a year per patient in the US, even though it could be produced for less than $40. Doctors Without Borders/Medecins Sans Frontieres (MSF)
• [New] New drug development programs could grow by more than 10% in three to five years. Mimir's Well
• [New] As synthetic drugs continue to reshape global drug markets, timely surveillance and public health responses will be essential to reducing harm and protecting communities worldwide. recovered
• [New] Generative AI, combined with other computational tools, could cut drug discovery timelines by as much as 50%. MIT Technology Review
• [New] Drug discovery and materials science are projected to expand at a 31.48% CAGR through 2031, which makes it the fastest-growing application area. Mordor Intelligence
• [New] The U.S. is the largest in North America and is expected to reach ~ US$ 18 Bn by 2026 (derived from OTC pharmaceutical consumption patterns and national health expenditure trends reported by CDC-linked wellness data and NIH nutritional studies). Persistence Market Research
• [New] AI has not yet produced an FDA-approved drug, and skeptics warn the ~90% drug failure rate could persist if models do not adequately account for human biological variation. The Brief - Superculture
• [New] Tirzepatide alone is forecast to be worth more than $70 billion, the biggest drug ever. LinkedIn
• [New] The cancer generics segment is anticipated to witness the fastest CAGR of 11.6% from 2025 to 2033. Market Data Forecast
• [New] HB 1477/SB 527, which was introduced in February, would establish grants so that research institutions in Maryland could conduct certified clinical drug development trials about ibogaine as a treatment for opioid use disorder and other neurological conditions. UC Berkeley Center for the Science of Psychedelics
• Peptide-drug conjugates are especially notable, combining selective receptor binding with targeted delivery, and one analysis projects roughly 20% annual growth through 2035. Doctor NHS
• China is projected to exhibit rapid volume growth driven by expanding centralized drug procurement programs and heavy state investments in urban hospital infrastructure. Persistence Market Research

Last updated: 11 August 2026